Cymbalta for Generalized Anxiety Disorder
Sunday March 4, 2007
According to a press release from drug maker Eli Lilly, their medication Cymbalta has been approved by the FDA to treat Generalized Anxiety Disorder (GAD). The release cites 3 clincal trials that showed the medication being more effective than placebo at reducing symptoms of GAD. Therefore, those of you that have GAD and are exploring treatment options can include this on the list. I'm more than 100% positive that a massive TV and magazine ad campaign is on the way...

Comments
No comments yet. Leave a Comment